Picture of Cryo-Cell International logo

CCEL Cryo-Cell International Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapHigh Flyer

Annual cashflow statement for Cryo-Cell International, fiscal year end - November 30th, USD millions except per share, conversion factor applied.

2019
November 30th
2020
November 30th
2021
November 30th
2022
November 30th
2023
November 30th
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line2.293.622.082.77-9.52
Depreciation
Deferred Taxes
Non-Cash Items2.8721.591.7817.8
Unusual Items
Other Non-Cash Items
Changes in Working Capital2.283.764.864.255.99
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities6.328.477.938.578.92
Capital Expenditures-0.662-0.1-1.84-12.2-6.84
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-0.0280.457-5.11-3.11-1.31
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Cash from Investing Activities-0.6910.357-6.95-15.3-8.14
Financing Cash Flow Items-0.045-0.0450-0.197-0.068
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-5.13-5-3.070.148-2.07
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash0.5013.82-2.1-6.56-1.3